Fast Track Hip Fracture - an Optimized Pathway for Hip Fracture Patients
Influence of a Fast Track Pathway for Hip Fracture Patients on Mortality and Quality of Life
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Operated at Akershus university hospital for a hip fracture (neck of femur, trochanteric, subtrochanteric) in 2012, 2013, 2014 or 2015
- 18 years or older
Exclusion Criteria:
- stress fracture
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Standard care
Hip fracture patients operated at Akershus University hospital in 2012 and 2013.
|
|
|
Fast track patient pathway
Hip fracture patients operated at Akershus University hospital in 2014 and 2015.
|
Admittance: Ambulance - Radiology - Orthopaedic ward.
Focus on preoperative information, stress reduction, pain relief, early mobilization and nutritional status.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
30 day mortality rate
Time Frame: Within 30 days from surgery
|
Percentage of patients who die within 30 days from hip fracture surgery
|
Within 30 days from surgery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1 year mortality rate
Time Frame: Within 1 year from surgery
|
Percentage of patients who die within 1 year from hip fracture surgery
|
Within 1 year from surgery
|
|
Quality of life
Time Frame: 4 and 12 months from surgery
|
Quality of life measured by EQ-5D
|
4 and 12 months from surgery
|
|
Readmissions
Time Frame: Within 30 days from discharge
|
Unscheduled, all-cause readmission within 30 days from discharge from the index admission
|
Within 30 days from discharge
|
|
Postoperative infection
Time Frame: Within 1 year from surgery
|
Superficial and / or deep surgical site infection
|
Within 1 year from surgery
|
|
Re-operation
Time Frame: Within 1 year from surgery
|
All-cause re-operation at the site of the index surgery
|
Within 1 year from surgery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Asbjorn Aaroen, Professor, Akershus University Hospital and Faculty of Medicine, University of Oslo
Study record dates
Study Major Dates
Study Start (ACTUAL)
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 284907
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.